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A B S T R A C T
Knowledge that older people are vulnerable to develop tuberculosis is rarely considered in developing
country settings. According to 2010 Global Burden of Disease estimates, the majority of tuberculosis-
related deaths occurred among people older than 50; most in those aged 65 and above. Older people also
contribute a large proportion of Disability-Adjusted Life Years (DALYs); 51% of tuberculosis DALYs
occurred in patients aged 50 years and older in East Asia. Tuberculosis age distributions in Africa have
been severely skewed by the human immunodeﬁciency virus (HIV) epidemic, but emerging data suggest
increasing disease burdens among older people. Older adults are more likely to develop extra-pulmonary
and atypical forms of disease that are often harder to diagnose than conventional sputum smear-positive
pulmonary tuberculosis. Their care is complicated by more frequent drug-related adverse events and
increased co-morbidity, which may prove difﬁcult to manage in regions where health resources are
already constrained. Health systems will have to confront the challenge of an ageing global population
and the integrated services required to address their health needs.
 2014 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/3.0/).
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Tuberculosis continues to be a world-leading cause of disease
and death, particularly in low- and middle-income countries,
which carry the bulk (>95%) of the global tuberculosis disease
burden.1 Despite reductions in tuberculosis-related mortality and
being on track to achieve Millennium Development Goal targets in
most regions, progress has been sub-optimal in areas affected by
human immune-deﬁciency virus (HIV) infection, poverty and
drug-resistance.2,3 In recent years, there has been increased focus
on active case ﬁnding among groups considered to be vulnerable to
develop tuberculosis, including people living with HIV,4 people
with diabetes5 and children.6 However, despite increased attention
on vulnerable groups, there has been ongoing neglect of older
adults, especially in low and middle-income countries.* Corresponding author. Senior Lecturer in International Public Health, Sydney
School of Public Health, University of Sydney, Edward Ford Building (A27), Sydney,
NSW, Australia 2006. Tel.: +61-2-9114-0974.
E-mail address: joel.negin@sydney.edu.au (J. Negin).
http://dx.doi.org/10.1016/j.ijid.2014.11.018
1201-9712/ 2014 The Authors. Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).2. Age-related burden of disease
It has long been recognised that older people are vulnerable to
develop tuberculosis.7 This is widely acknowledged in high-
income countries, but rarely considered in developing country
settings. The 2010 Global Burden of Disease estimates show that
57% of all tuberculosis deaths globally occurred among people
older than 50, with more than half of these deaths in those aged
65 and above.8 While the proportion of tuberculosis deaths among
those aged 50 and older is highest in high-income countries (92% in
Australasia and 93% in Western Europe), it also reaches high
proportions in East Asia (79%) and in Tropical Latin America (65%).8
While comparative death ratios provide a biased readout when
assessing relative health impacts in older and younger adults,
Disability-Adjusted Life Years (DALYs) provide a more objective
measure. Interestingly, older people also contribute a large
proportion of DALYs attributable to tuberculosis. Globally, 34%
of tuberculosis DALY’s occur in patients aged 50 years and older,
rising to 51% in East Asia and 39% in South Asia (Table 1).8
A national tuberculosis prevalence survey, conducted in China
in 2010, revealed relatively stable and low tuberculosis prevalence
rates up to age 40 after which prevalence more than quadruples tociety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
Table 1
Disability Adjusted Life Years (DALYs) lost due to tuberculosis among older adults8
Region All Ages 50+ % of
Total
65+ % of
Total
Global 49,396,246 16,793,978 34.0% 6,200,008 12.6%
South Asia 19,996,683 7,701,170 38.5% 2,942,024 14.7%
sub-Saharan Africa 13,690,695 3,345,835 24.4% 1,170,486 8.5%
Southeast Asia 9,393,998 3,294,984 35.1% 1,156,370 12.3%
East and Central Asia 2,417,923 1,086,216 44.9% 453,316 18.7%
Europe 1,520,711 533,921 35.1% 125,146 8.2%
Latin America and
Caribbean
1,078,652 378,733 35.1% 145,101 13.5%
North Africa and
Middle East
885,590 237,988 26.9% 88,593 10.0%
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most pronounced in Chinese men. Register-based data from Hunan
Province in China showed that the prevalence of tuberculosis was
more than twice as high in those aged 65 years and older than in
younger adults (aged 15–64).10 Older adults in India, which has the
highest proportion of tuberculosis cases globally, face further
complications due to the presence of drug-resistant strains of
tuberculosis11,12. The elderly in some regions in India are
estimated to make up 14% of all tuberculosis patients and have
a higher likelihood of unfavourable outcomes due to drug-related
adverse events, increased co-morbidity, and a higher rate of
poverty than younger adults.13,14
Similarly, within the Americas, the disease burden among older
adults appears to be increasing; the highest smear-positive
tuberculosis case notiﬁcation rates occurred in adults older than
55 in Andean, Central American and North American countries in
2010.15 A study which examined tuberculosis rates in Brazil,
Uruguay, Mexico, Chile and Venezuela found that older adults were
particularly vulnerable to develop active tuberculosis within these
countries; point estimates from the PLATINO study found 2.3% of
50-59 year-olds and 3.4% of adults over 60 had a medical diagnosis
of tuberculosis.16 This was two-fold higher than disease rates
recorded in adults between 40-49 years of age. These observations
are very similar to ﬁndings in the United States where consistently
higher incidence and mortality rates have been reported in people
older than 65 years of age.17
Although tuberculosis age distributions in Africa have been
severely skewed by the HIV epidemic in recent years, emerging
data suggest increasing disease burdens among older people. In
South Africa, one of the data rich African countries with
exceptionally high TB incidence rates, there has been a paucity
of research on the topic. Until Karstaedt and Bolhaar’s 2014 article
on tuberculosis in Soweto, no study on tuberculosis among the
elderly in Southern Africa had been published since 1989.18 Their
ﬁndings suggest that older adults in Soweto bear a high burden of
tuberculosis, comprising 5.8% of all adults with tuberculosis.
Furthermore, 50% of the older adults with tuberculosis were found
to have extra-pulmonary tuberculosis.
In 2012, a national tuberculosis survey done in Tanzania
demonstrated an epidemic shift from young HIV-infected to older
HIV-uninfected people19. National tuberculosis program data
reported HIV infection rates of 30% among tuberculosis cases,
but the population-based survey revealed that only 7% of prevalent
cases were HIV-infected. The prevalence rate was highest among
those older than 45 years, in whom HIV infection rates were
generally lower. In his analysis of the data, Law suggests that an
overemphasis on joint tuberculosis and HIV activities diverted
attention away from a large unidentiﬁed population of older HIV-
uninfected adults with active tuberculosis who may not be able
access care as readily as younger people.193. Undetected cases among older people
It seems likely that there is a considerable burden of
undiagnosed tuberculosis among older adults in many low and
middle-income countries. During a community-based active case
ﬁnding project among the urban poor in Cambodia, the median age
of newly identiﬁed tuberculosis cases was 45 years.20 Of all cases
found through active case ﬁnding, 26% were older than 65; double
the proportion of cases found in this age group through passive
case ﬁnding (13%).21 Similarly, repeated tuberculosis prevalence
surveys conducted in Cambodia record a clear age shift. In
2002 most cases were young adults, but by 2011 two-thirds of
tuberculosis cases were older than 45 years. Data from the
2011 national prevalence survey revealed that tuberculosis
prevalence rates were more than twice as high as case notiﬁcation
rates among adults older than 45 years.
Various factors related to old age can cause complications in the
diagnosis, treatment and disease outcomes for tuberculosis
patients. Older adults are more likely to develop atypical forms
of tuberculosis such as tuberculous meningitis, renal or skeletal
disease, or sputum smear-negative pulmonary involvement; forms
of disease that are often harder to diagnose and treat than
conventional pulmonary tuberculosis.17,22,23 Difﬁculties in diag-
nosis tuberculosis in older adults has been assessed in a meta-
analysis of studies focusing on tuberculosis in older adults, which
found that common symptoms used to identify tuberculosis such
as dyspnoea, haemoptysis and fever are less prominent in older
than in younger adults.23 Older adults also have a reduced ability to
produce a high quality sputum specimen. Furthermore, one of the
most common tests that assists a diagnosis of sputum smear-
negative tuberculosis, the Mantoux skin test, tends to produce false
negative results in older patients.23–26
4. Increased vulnerability
A number of factors underlie the high and rising rates of
tuberculosis seen among older adults in low- and middle-income
countries (LMICs). Increased life expectancy changes the demo-
graphic proﬁle.27 With increased numbers of older people the
proportion of both tuberculosis-related deaths and DALYs among
older adults is likely to rise. But it is not only about relative
numbers, older adults tend to be more vulnerable as a group than
younger adults. This may be ascribed to compromised immune
responses resulting from increased co-morbidity,28 due to a range
of chronic diseases (e.g. diabetes or chronic lung disease) and
immunosuppressive therapy (with arthritis, organ transplants or
cancer etc.), and age-related immune-senescence.
Diabetes triples the risk for active tuberculosis, so with rates of
diabetes rapidly rising in many tuberculosis endemic areas, it is
likely that the present tuberculosis epidemic will be sustained – in
particular among older people most affected by diabetes.29
Glycaemic control, necessary to address diabetes and also to
improve tuberculosis outcomes, is particularly challenging in the
context of multi-morbidity. Co-infection is associated with poorer
treatment outcomes. For example, individuals co-infected with
tuberculosis and diabetes in China were 4.5 times more likely to
fail treatment than those with tuberculosis only.30
It is evident that there is an increasing pool of vulnerable older
adults who may develop active tuberculosis by reactivation of
previous ‘‘latent’’ or new M. tuberculosis infection. In high-income
countries, older people cluster in aged-care facilities where they may
be exposed to tuberculosis.31 In LMICs, exposure may occur in
crowded homes or places of socialization. Relatively large propor-
tions of the elderly population of certain countries in Latin America
live in urban or peri-urban slums; with a lack of adequate
sanitation and overcrowding creating a perfect environment for
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frequently meet at local temples, where poor ventilation may
increase their risk of tuberculosis exposure. At the same time, social
marginalisation, reduced mobility and ﬁnancial dependency often
discourage health care seeking. This may delay diagnosis, leading to
worse outcomes and potentially prolonged transmission.32 Older
carers with tuberculosis also pose a risk to vulnerable young children
in settings where grandparents often perform child-care duties.
5. Into the future
Although currently underappreciated, tuberculosis among
older adults will pose major challenges to global tuberculosis
control in the future. There is sufﬁcient data to articulate a clear
concern, but not enough to understand the full scale and
underlying determinants of the problem. Recognition is a critical
ﬁrst step. World Tuberculosis Day focused on children in 2012;33
similar acknowledgement of older adults would raise awareness
and pave the way for action. Future tuberculosis surveys should
include a speciﬁc focus on older adults, while national tuberculosis
programs should consider active case ﬁnding among older people
and their inclusion in prevention strategies.34 In addition, with
massive scale up of anti-retroviral treatment in LMICs, HIV-
infected patients are living into old age and their contribution to
the tuberculosis disease burden is likely to increase over time.35,36
Tuberculosis treatment outcomes in older adults are often poorer
due to delayed diagnosis, increased rates of drug-related adverse
events, frequent co-morbidity and overarching poverty.37,38 Tar-
geted efforts to improve case detection and treatment outcomes in
this population are needed to achieve global tuberculosis targets.
Focussed outreach services to places where older adults congregate –
be they temples, social clubs or old-age homes – are needed along
with clinical training to assist diagnosis and optimal case manage-
ment. Caring for increasing numbers of older adults with tuberculo-
sis may prove difﬁcult in regions where health resources are already
constrained, but health systems will have toconfront the challenge of
an aging population and the integrated services required to address
their health needs. This also emphasizes the need to include older
people in the assessment of new tuberculosis drugs.
Older adults provide society’s carers, community leaders and
mentors, and play an important role in educating the younger
generation. Including them as a key population in tuberculosis
prevention, active case ﬁnding and treatment interventions will
have positive cascading effects through families, communities and
societies.
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